Cell Therapeutics (CTIC) to Acquire Rights on S*BIO's Pacritinib JAK2 Inhibitor
Go back to Cell Therapeutics (CTIC) to Acquire Rights on S*BIO's Pacritinib JAK2 Inhibitor| CELL THERAPEUTICS (NASDAQ: CTIC) | Delayed: 9.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.09 | 52 Week High | $1.34 | |||
| Open | $9.91 | 52 Week Low | $0.25 | |||
| Day High | $9.09 | P/E | N/A | |||
| Day Low | $9.09 | EPS | $-0.42 | |||
| Volume | 253 | |||||
